<?xml version="1.0"?>
<rss version="2.0" xmlns:atom='http://www.w3.org/2005/Atom'>
<channel>
    <atom:link href="https://feeds.thelocal.com/rss/dk/pharmaceutical" rel="self" type="application/rss+xml"/>
    <title>The Local Denmark</title>
    <link>https://feeds.thelocal.com/</link>
    <description>Read the latest news and views from Denmark in English</description>
    <language>en-us</language>
    <managingEditor>news@thelocal.com (TheLocal)</managingEditor>
    <webMaster>webmaster@thelocal.com (TheLocal)</webMaster>
    <generator>TheLocal RSS Feed</generator>

        <item>
        <title>
            Novo Nordisk profits rise from insulin sales
        </title>
        <description>
            The world&#039;s top insulin maker, Denmark&#039;s Novo Nordisk, reported on Thursday a slight profit increase in the third quarter as sales rose.

        </description>
        <link>
            https://www.thelocal.dk/20141030/novo-nordisk-reports-strong-profits-from-insulin-sales
        </link>
        <pubDate>Thu, 30 Oct 2014 17:39:00 +0100</pubDate>
        <enclosure url="https://assets.thelocal.com/cdn-cgi/plain/https://apiwp.thelocal.com/wp-content/uploads/2014/10/1ede8ad25320dce711a02971f430535cad2b2a264a09ce33a29a7a78cbd7a33e.jpg@webp" length="500" type="image/jpg"/>
        <guid isPermaLink="false">novo-nordisk-reports-strong-profits-from-insulin-sales</guid>
    </item>
        <item>
        <title>
            Novo has best-perfoming CEO outside of US
        </title>
        <description>
            Novo Nordisk’s Lars Rebien Sørensen was the top-ranked non-American on Harvard Business Review&#039;s list of the world&#039;s best CEOs, coming in at number six overall. 
        </description>
        <link>
            https://www.thelocal.dk/20141016/novo-has-best-perfoming-ceo-outside-of-us
        </link>
        <pubDate>Thu, 16 Oct 2014 11:03:00 +0200</pubDate>
        <enclosure url="https://assets.thelocal.com/cdn-cgi/plain/https://apiwp.thelocal.com/wp-content/uploads/2014/10/d2e503759f16302892982eb39c1cfc0d5297cae7d861c84e152bfb481cfae401.jpg@webp" length="500" type="image/jpg"/>
        <guid isPermaLink="false">novo-has-best-perfoming-ceo-outside-of-us</guid>
    </item>
        <item>
        <title>
            Novo shares rise as US panel backs obesity drug
        </title>
        <description>
            US authorities are expected to follow the advice of an advisory panel and approve Novo Nordisk&#039;s Saxenda for the American market, where 35 percent of adults are obese. 
        </description>
        <link>
            https://www.thelocal.dk/20140912/novo-nordisk-shares-rise-as-us-panel-backs-obesity-drug
        </link>
        <pubDate>Fri, 12 Sep 2014 21:50:00 +0200</pubDate>
        <enclosure url="https://assets.thelocal.com/cdn-cgi/plain/https://apiwp.thelocal.com/wp-content/uploads/2014/09/ed06c2bf5dc5fe1e9e72b7891497c7f264fb0499a096aeb6a228d2aa38804874.jpg@webp" length="500" type="image/jpg"/>
        <guid isPermaLink="false">novo-nordisk-shares-rise-as-us-panel-backs-obesity-drug</guid>
    </item>
        <item>
        <title>
            Novo Nordisk reports progress on US permit
        </title>
        <description>
            The company on Thursday reported an four percent increase in the second quarter and said that its insulin drug Tresiba could hit the US market ahead of its competitors. 
        </description>
        <link>
            https://www.thelocal.dk/20140807/novo-nordisk-reports-profit-rise-and-progress-on-us-permit
        </link>
        <pubDate>Thu, 07 Aug 2014 15:27:00 +0200</pubDate>
        <enclosure url="https://assets.thelocal.com/cdn-cgi/plain/https://apiwp.thelocal.com/wp-content/uploads/2014/08/4022e81fc6a479c6083fc51fa0885183f86f5e808ba68bda193eccf793d0f0d0.jpg@webp" length="500" type="image/jpg"/>
        <guid isPermaLink="false">novo-nordisk-reports-profit-rise-and-progress-on-us-permit</guid>
    </item>
    </channel> 
</rss> 